Postconditioning with rosuvastatin reduces myocardial ischemia-reperfusion injury by inhibiting high mobility group box 1 protein expression

High mobility group box 1 protein (HMGB1) plays an important role in myocardial ischemia-reperfusion (I/R) injury. Rosuvastatin (RS) preconditioning has been reported to reduce myocardial I/R injury. The aim of this study was to investigate whether postconditioning with RS is able to reduce myocardi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental and therapeutic medicine 2014-01, Vol.7 (1), p.117-120
Hauptverfasser:	DU, XIANJIN, HU, XIAORONG, WEI, JIE
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioengineering Cytokines Dehydrogenases Drug therapy Gene expression Genetic aspects Health aspects high mobility group box 1 protein Ischemia Laboratory animals Myocardial ischemia Ostomy Oxidative stress Proteins reperfusion Risk factors Rodents Rosuvastatin Statistical analysis Studies Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!